Description
Letrozole, marketed under the brand name Femara, It is an prescription medication that has been approved letrozole (Femara) for the treatment of breast cancer in postmenopausal women on July 25, 1997.
What is Femara (letrozole) ?
Femara is an aromatase inhibitor indicated for:
Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer
Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy
First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer
Quote From Novartis Pharmaceuticals
How to order approved “Femara (letrozole) for tablets” Medicine?
Femara (Letrozole) tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Femara and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





